Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2010-09-30
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Safety and Tolerability of AFFITOPE AD01
NCT00711139
Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
NCT01357629
Long-term Safety and Tolerability of AFFITOPE AD02
NCT00711321
Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02
NCT01093664
Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A
NCT01568086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AD01with or without adjuvant
Patients who have received at least one immunization of AD01 with or without adjuvant during AFF001
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients having participated in AFFiRiS 001 and AFF003 and having received ≥1 vaccination with AFFITOPE AD01
* Availability of a partner/caregiver knowing the patient
Exclusion Criteria
* History of questionable compliance to visit schedule
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Affiris AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AFFiRiS AG
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Dal-Bianco, MD
Role: PRINCIPAL_INVESTIGATOR
Univ. Klinik für Neurologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univ. Klinik für Neurologie
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AFF003E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.